ILMN vs TSHA · rev $2.25B vs $640.7M cap
Illumina Inc (ILMN) versus Taysha Gene Therapies Inc (TSHA) — a side-by-side from cached financials, not a winner call.
Illumina Inc (ILMN) is a diagnostics & research company listed on US.
Taysha Gene Therapies Inc (TSHA) is a biotechnology company listed on US.
Latest reported ILMN revenue for 2026-06-28 was $2.25B. Net income was $340.0M. ILMN currently screens at market cap $15.84B.
Latest reported TSHA revenue for 2026-06-30 was $0. Net income was -$89.0M. TSHA currently screens at market cap $640.7M.
ILMN currently screens at market cap $15.84B. TSHA currently screens at market cap $640.7M.
Not investment advice. Open the ILMN and TSHA stock pages for the full models.
Not investment advice.